Literature DB >> 30201760

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer.

Germán Corredor1,2, Xiangxue Wang1, Yu Zhou1, Cheng Lu1, Pingfu Fu3, Konstantinos Syrigos4, David L Rimm5, Michael Yang6, Eduardo Romero2, Kurt A Schalper5, Vamsidhar Velcheti7, Anant Madabhushi8.   

Abstract

PURPOSE: The presence of a high degree of tumor-infiltrating lymphocytes (TIL) has been proven to be associated with outcome in patients with non-small cell lung cancer (NSCLC). However, recent evidence indicates that tissue architecture is also prognostic of disease-specific survival and recurrence. We show a set of descriptors (spatial TIL, SpaTIL) that capture density, and spatial colocalization of TILs and tumor cells across digital images that can predict likelihood of recurrence in early-stage NSCLC. EXPERIMENTAL
DESIGN: The association between recurrence in early-stage NSCLC and SpaTIL features was explored on 301 patients across four different cohorts. Cohort D1 (n = 70) was used to identify the most prognostic SpaTIL features and to train a classifier to predict the likelihood of recurrence. The classifier performance was evaluated in cohorts D2 (n = 119), D3 (n = 112), and D4 (n = 112). Two pathologists graded each sample of D1 and D2; intraobserver agreement and association between manual grading and likelihood of recurrence were analyzed.
RESULTS: SpaTIL was associated with likelihood of recurrence in all test sets (log-rank P < 0.02). A multivariate Cox proportional hazards analysis revealed an HR of 3.08 (95% confidence interval, 2.1-4.5, P = 7.3 × 10-5). In contrast, agreement among expert pathologists using tumor grade was moderate (Kappa = 0.5), and the manual TIL grading was only prognostic for one reader in D2 (P = 8.0 × 10-3).
CONCLUSIONS: A set of features related to density and spatial architecture of TILs was found to be associated with a likelihood of recurrence of early-stage NSCLC. This information could potentially be used for helping in treatment planning and management of early-stage NSCLC.See related commentary by Peled et al., p. 1449. ©2018 American Association for Cancer Research.

Entities:  

Year:  2018        PMID: 30201760      PMCID: PMC6397708          DOI: 10.1158/1078-0432.CCR-18-2013

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  68 in total

1.  Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Authors:  Zuzana Kos; Elvire Roblin; Rim S Kim; Stefan Michiels; Brandon D Gallas; Weijie Chen; Koen K van de Vijver; Shom Goel; Sylvia Adams; Sandra Demaria; Giuseppe Viale; Torsten O Nielsen; Sunil S Badve; W Fraser Symmans; Christos Sotiriou; David L Rimm; Stephen Hewitt; Carsten Denkert; Sibylle Loibl; Stephen J Luen; John M S Bartlett; Peter Savas; Giancarlo Pruneri; Deborah A Dillon; Maggie Chon U Cheang; Andrew Tutt; Jacqueline A Hall; Marleen Kok; Hugo M Horlings; Anant Madabhushi; Jeroen van der Laak; Francesco Ciompi; Anne-Vibeke Laenkholm; Enrique Bellolio; Tina Gruosso; Stephen B Fox; Juan Carlos Araya; Giuseppe Floris; Jan Hudeček; Leonie Voorwerk; Andrew H Beck; Jen Kerner; Denis Larsimont; Sabine Declercq; Gert Van den Eynden; Lajos Pusztai; Anna Ehinger; Wentao Yang; Khalid AbdulJabbar; Yinyin Yuan; Rajendra Singh; Crispin Hiley; Maise Al Bakir; Alexander J Lazar; Stephen Naber; Stephan Wienert; Miluska Castillo; Giuseppe Curigliano; Maria-Vittoria Dieci; Fabrice André; Charles Swanton; Jorge Reis-Filho; Joseph Sparano; Eva Balslev; I-Chun Chen; Elisabeth Ida Specht Stovgaard; Katherine Pogue-Geile; Kim R M Blenman; Frédérique Penault-Llorca; Stuart Schnitt; Sunil R Lakhani; Anne Vincent-Salomon; Federico Rojo; Jeremy P Braybrooke; Matthew G Hanna; M Teresa Soler-Monsó; Daniel Bethmann; Carlos A Castaneda; Karen Willard-Gallo; Ashish Sharma; Huang-Chun Lien; Susan Fineberg; Jeppe Thagaard; Laura Comerma; Paula Gonzalez-Ericsson; Edi Brogi; Sherene Loi; Joel Saltz; Frederick Klaushen; Lee Cooper; Mohamed Amgad; David A Moore; Roberto Salgado
Journal:  NPJ Breast Cancer       Date:  2020-05-12

Review 2.  Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Authors:  Mohamed Amgad; Elisabeth Specht Stovgaard; Eva Balslev; Jeppe Thagaard; Weijie Chen; Sarah Dudgeon; Ashish Sharma; Jennifer K Kerner; Carsten Denkert; Yinyin Yuan; Khalid AbdulJabbar; Stephan Wienert; Peter Savas; Leonie Voorwerk; Andrew H Beck; Anant Madabhushi; Johan Hartman; Manu M Sebastian; Hugo M Horlings; Jan Hudeček; Francesco Ciompi; David A Moore; Rajendra Singh; Elvire Roblin; Marcelo Luiz Balancin; Marie-Christine Mathieu; Jochen K Lennerz; Pawan Kirtani; I-Chun Chen; Jeremy P Braybrooke; Giancarlo Pruneri; Sandra Demaria; Sylvia Adams; Stuart J Schnitt; Sunil R Lakhani; Federico Rojo; Laura Comerma; Sunil S Badve; Mehrnoush Khojasteh; W Fraser Symmans; Christos Sotiriou; Paula Gonzalez-Ericsson; Katherine L Pogue-Geile; Rim S Kim; David L Rimm; Giuseppe Viale; Stephen M Hewitt; John M S Bartlett; Frédérique Penault-Llorca; Shom Goel; Huang-Chun Lien; Sibylle Loibl; Zuzana Kos; Sherene Loi; Matthew G Hanna; Stefan Michiels; Marleen Kok; Torsten O Nielsen; Alexander J Lazar; Zsuzsanna Bago-Horvath; Loes F S Kooreman; Jeroen A W M van der Laak; Joel Saltz; Brandon D Gallas; Uday Kurkure; Michael Barnes; Roberto Salgado; Lee A D Cooper
Journal:  NPJ Breast Cancer       Date:  2020-05-12

Review 3.  Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics.

Authors:  Mayar Allam; Shuangyi Cai; Ahmet F Coskun
Journal:  NPJ Precis Oncol       Date:  2020-05-01

4.  Reimagining T Staging Through Artificial Intelligence and Machine Learning Image Processing Approaches in Digital Pathology.

Authors:  Kaustav Bera; Ian Katz; Anant Madabhushi
Journal:  JCO Clin Cancer Inform       Date:  2020-11

Review 5.  Applications of machine learning in drug discovery and development.

Authors:  Jessica Vamathevan; Dominic Clark; Paul Czodrowski; Ian Dunham; Edgardo Ferran; George Lee; Bin Li; Anant Madabhushi; Parantu Shah; Michaela Spitzer; Shanrong Zhao
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

6.  Computational Staining of Pathology Images to Study the Tumor Microenvironment in Lung Cancer.

Authors:  Shidan Wang; Ruichen Rong; Donghan M Yang; Junya Fujimoto; Shirley Yan; Ling Cai; Lin Yang; Danni Luo; Carmen Behrens; Edwin R Parra; Bo Yao; Lin Xu; Tao Wang; Xiaowei Zhan; Ignacio I Wistuba; John Minna; Yang Xie; Guanghua Xiao
Journal:  Cancer Res       Date:  2020-01-08       Impact factor: 12.701

7.  CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.

Authors:  Pranjal Vaidya; Kaustav Bera; Amit Gupta; Xiangxue Wang; Germán Corredor; Pingfu Fu; Niha Beig; Prateek Prasanna; Pradnya Patil; Priya Velu; Prabhakar Rajiah; Robert Gilkeson; Michael Feldman; Humberto Choi; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Lancet Digit Health       Date:  2020-02-13

8.  Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findings.

Authors:  Germán Corredor; Paula Toro; Kaustav Bera; Dylan Rasmussen; Vidya Sankar Viswanathan; Christina Buzzy; Pingfu Fu; Lisa M Barton; Edana Stroberg; Eric Duval; Hannah Gilmore; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Med Imaging (Bellingham)       Date:  2021-07-13

Review 9.  Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.

Authors:  Kaustav Bera; Kurt A Schalper; David L Rimm; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Nat Rev Clin Oncol       Date:  2019-08-09       Impact factor: 66.675

10.  An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.

Authors:  Balazs Acs; David L Rimm; Yalai Bai; Kimberly Cole; Sandra Martinez-Morilla; Fahad Shabbir Ahmed; Jon Zugazagoitia; Johan Staaf; Ana Bosch; Anna Ehinger; Emma Nimeus; Johan Hartman
Journal:  Clin Cancer Res       Date:  2021-06-04       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.